loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 207027 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 NOVARTIS (2)

filter

01 FOR SUSPENSION;ORAL (2)

filter

01 RX (2)

filter

01 PROMACTA KIT (2)

filter

01 Yes (2)

URL Supplier Web Content
FOR SUSPENSION; OR...
EQ 12.5MG ACID/PAC...
2018-09-27
207027
PROMACTA KIT
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
FOR SUSPENSION; OR...
EQ 25MG ACID/PACKE...
2015-08-24
207027
PROMACTA KIT
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 207027

Looking for FDA Orange Book APPLICATION 207027 2

19

Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is ELTROMBOPAG OLAMINE, with a corresponding application number 207027.

Regulatory Information RX

With a dosage strength EQ 12.5MG ACID/PACKET

Dosage Form Route FOR SUSPENSION; ORAL

Reference Listed Drug Yes

Approved since 2018-09-27

18

Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is ELTROMBOPAG OLAMINE, with a corresponding application number 207027.

Regulatory Information RX

With a dosage strength EQ 25MG ACID/PACKET

Dosage Form Route FOR SUSPENSION; ORAL

Reference Listed Drug Yes

Approved since 2015-08-24

Post Enquiry
POST ENQUIRY